Assignee
ATHEROGENICS INC
US25 patents
Top patents by PatentIndex Score
US6147250ANov 14, 2000
Compounds and methods for the inhibition of the expression of VCAM-1
ATHEROGENICS INC108 citations97
US6121319ASep 19, 2000
Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
ATHEROGENICS INC107 citations97
US6602914B2Aug 5, 2003
Compounds and methods for the inhibition of the expression of VCAM-1
ATHEROGENICS INC24 citations96
US6617352B2Sep 9, 2003
Compounds and methods for the inhibition of the expression of VCAM-1
ATHEROGENICS INC25 citations95
US6548699B1Apr 15, 2003
Compounds and methods for the inhibition of the expression of VCAM-1
ATHEROGENICS INC38 citations95
US6670398B2Dec 30, 2003
Compounds and methods for treating transplant rejection
ATHEROGENICS INC63 citations94
US7375252B2May 20, 2008
Compounds and method for the inhibition of the expression of VCAM-1
ATHEROGENICS INC9 citations92
US6887712B1May 3, 2005
Methods and compositions to lower plasma cholesterol levels
ATHEROGENICS INC53 citations92
US6828447B2Dec 7, 2004
Compounds and methods for the inhibition of the expression of VCAM-1
ATHEROGENICS INC13 citations92
US6881860B2Apr 19, 2005
Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
ATHEROGENICS INC27 citations91
US6608101B1Aug 19, 2003
1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
ATHEROGENICS INC53 citations90
US6852878B2Feb 8, 2005
Thioketals and thioethers for inhibiting the expression of VCAM-1
ATHEROGENICS INC30 citations88
US7247714B2Jul 24, 2007
Protection against oxidative stress and inflammation by a cytoprotective response element
ATHEROGENICS INC18 citations86
US7094801B2Aug 22, 2006
Chalcone derivatives and their use to treat diseases
ATHEROGENICS INC15 citations80
US7071158B2Jul 4, 2006
Antioxidant enhancement of therapy for hyperproliferative conditions
ATHEROGENICS INC13 citations75
US7371895B2May 13, 2008
Salt forms of poorly soluble probucol esters and ethers
ATHEROGENICS INC5 citations73
US6960683B2Nov 1, 2005
Salt forms of poorly soluble probucol esters and ethers
ATHEROGENICS INC9 citations73
US7087645B2Aug 8, 2006
Compounds and methods for treating transplant rejection
ATHEROGENICS INC9 citations72
US7273948B2Sep 25, 2007
Process of preparing esters and ethers of probucol and derivatives thereof
ATHEROGENICS INC4 citations61
US6747061B2Jun 8, 2004
N-substituted dithiocarbamates for the treatment of biological disorders
ATHEROGENICS INC4 citations61
US7294737B2Nov 13, 2007
Process of preparing esters and ethers of probucol and derivatives thereof
ATHEROGENICS INC5 citations60
US7078431B2Jul 18, 2006
1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
ATHEROGENICS INC4 citations60
US7183317B2Feb 27, 2007
Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality
ATHEROGENICS INC1 citations51
US7202247B2Apr 10, 2007
1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
ATHEROGENICS INC0 citations41
US7173129B2Feb 6, 2007
Sulfonamide-substituted chalcone derivatives and their use to treat diseases
ATHEROGENICS INC0 citations36